Viewing Study NCT04745234


Ignite Creation Date: 2025-12-25 @ 2:19 AM
Ignite Modification Date: 2026-02-01 @ 12:30 PM
Study NCT ID: NCT04745234
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-25
First Post: 2021-01-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Mogamulizumab Q4week Dosing in Participants With R/R CTCL
Sponsor: Kyowa Kirin, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cutaneous T-Cell Lymphoma, Relapsed View
None Cutaneous T-Cell Lymphoma Refractory View
Keywords: